Osteogenics Biomedical, Inc.

Osteogenics Biomedical, Inc. is a prominent player in the health care and manufacturing industries. Based in Lubbock, Texas, the company has been leading the way in groundbreaking dental bone grafting since its establishment in 1996. Osteogenics Biomedical caters to Periodontists, Oral & Maxillofacial Surgeons, and clinicians involved in regenerative and implant dentistry globally. The company's robust product line encompasses enCore® Combination and Mineralized Allografts, Zcore™ Xenograft, NovaBone® Dental Putty, Cytoplast™ PTFE membranes, Cytoplast™ collagen membranes, Vitala™ porcine collagen membranes, Cytoplast™ PTFE suture, and the Pro-fix™ Precision Fixation System. With a slogan that underlines its commitment to innovation in dental bone grafting, Osteogenics Biomedical is positioned as a leading force in the market. Despite not having publicly disclosed its last investment or the involved investors, the company's strong presence and pioneering products make it an intriguing prospect for potential venture capital interest. As the demand for advanced dental bone grafting solutions continues to grow, Osteogenics Biomedical's progressive approach and comprehensive product portfolio present an enticing opportunity for investment.